脐静脉
血管通透性
内皮
败血症
内皮干细胞
肿瘤坏死因子α
血管内皮生长因子
免疫学
医学
细胞生物学
生物
癌症研究
病理
内科学
体外
生物化学
血管内皮生长因子受体
作者
Yusuke Takei,Mitsuhiro Yamada,Koji Saito,Yoshinobu Kameyama,Takanori Aihara,Yudai Iwasaki,Toru Murakami,Yu Kaiho,Akira Ohkoshi,Daisuke Konno,Takuya Shiga,Kazuhiro Takahashi,Saori Ikumi,Hiroaki Toyama,Yutaka Ejima,Masanori Yamauchi
标识
DOI:10.1213/ane.0000000000006988
摘要
BACKGROUND: Currently, clinical indicators for evaluating endothelial permeability in sepsis are unavailable. Endothelium-derived extracellular vesicles (EDEVs) are emerging as biomarkers of endothelial injury. Platelet endothelial cell adhesion molecule (PECAM) and vascular endothelial (VE)-cadherin are constitutively expressed endothelial intercellular adhesion molecules that regulate intercellular adhesion and permeability. Herein, we investigated the possible association between EDEVs expressing intercellular adhesion molecules (PECAM + or VE-cadherin + EDEVs) and endothelial permeability and sepsis severity. METHODS: Human umbilical vein endothelial cells (HUVECs) were stimulated with tumor necrosis factor alpha (TNF-α) directly or after pretreatment with permeability-modifying reagents such as angiopoietin-1, prostacyclin, or vascular endothelial growth factor (VEGF) to alter TNF-α-induced endothelial hyperpermeability. Endothelial permeability was measured using the dextran assay or transendothelial electrical resistance. Additionally, a prospective cross-sectional observational study was conducted to analyze circulating EDEV levels in patients with sepsis. EDEVs were examined in HUVEC culture supernatants or patient plasma (nonsepsis, n = 30; sepsis, n = 30; septic shock, n = 42) using flow cytometry. The Wilcoxon rank-sum test was used for comparisons between 2 groups. Comparisons among 3 or more groups were performed using the Steel-Dwass test. Spearman’s test was used for correlation analysis. Statistical significance was set at P < .05. RESULTS: TNF-α stimulation of HUVECs significantly increased EDEV release and endothelial permeability. Pretreatment with angiopoietin-1 or prostacyclin suppressed the TNF-α-induced increase in endothelial permeability and inhibited the release of PECAM + and VE-cadherin + EDEVs. In contrast, pretreatment with VEGF increased TNF-α-induced endothelial permeability and the release of PECAM + and VE-cadherin + EDEVs. However, pretreatment with permeability-modifying reagents did not affect the release of EDEVs expressing inflammatory stimulus-inducible endothelial adhesion molecules such as E-selectin, intracellular adhesion molecule-1, or vascular cell adhesion molecule-1. The number of PECAM + EDEVs on admission in the septic-shock group (232 [124, 590]/μL) was significantly higher ( P = .043) than that in the sepsis group (138 [77,267]/μL), with an average treatment effect of 98/μL (95% confidence interval [CI], 2–270/μL), and the number of VE-cadherin + EDEVs in the septic-shock group (173 [76,339]/μL) was also significantly higher ( P = .004) than that in the sepsis group (81 [42,159]/μL), with an average treatment effect (ATE) of 79/μL (95% CI, 19–171/μL); these EDEV levels remained elevated until day 5. CONCLUSIONS: EDEVs expressing intercellular adhesion molecules (PECAM + or VE-cadherin + EDEVs) may reflect increased endothelial permeability and could be valuable diagnostic and prognostic markers for sepsis.
科研通智能强力驱动
Strongly Powered by AbleSci AI